Sandhya Sharma

Sandhya Sharma

Auto-generated profile, based on publicly available information

Sandhya Sharma

From the Department of Computer & Electrical Engineering and Computer Science, Florida Atlantic University, Boca Raton

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Biotechnology Advances
Verified
Journal Article
Closed access
SSSandhya Sharma
Sandhya Sharma
RZRachel Zhuang
Rachel Zhuang
MLMarisa Long
Marisa Long
MPMirjana Pavlovic
Mirjana Pavlovic
KKKevin Kang
Kevin Kang
Waseem AsgharWaseem Asghar
Waseem Asghar

11 August 2020 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Closed access
SSSandhya Sharma
Sandhya Sharma
AKAlamgir Kabir
Alamgir Kabir
WAWaseem Asghar
Waseem Asghar
Context.—: Zika virus (ZIKV) infection, primarily transmitted by mosquitoes, causes various neurologic disorders. To differentiate ZIKV from other arboviruses, such as dengue, chikungunya, and yellow fever viruses, a highly specific, sensitive, and automated detection system is needed for point-of-care (POC) settings. Objective.—: To detect ZIKV at POC settings, we have developed a fully automated lab-on-a-chip microfluidic platform for rapid disease detection by using reverse transcription loop–mediated isothermal amplification. Design.—: The developed setup consists of a microfluidic chip, a platform for magnetic actuation, and a heater along with the sensor to precisely control the temperature for the target amplification. The platform accurately controls the movement of the magnetic beads that enable the isolation and purification of the target nucleotides adhered to their surface for the amplification and disease detection on the microfluidic chip. Results.—: Within 40 minutes, change in color due to the presence of ZIKV amplicons was visually observed with the spiked plasma samples in the end point analysis. Also, we have accurately and specifically identified ZIKV in a small number of de-identified clinical samples. Conclusions.—: All-inclusive, the developed fully automated POC ZIKV diagnostic chip is rapid, simple, easy to use, inexpensive, and suitable for the areas where facilities are limited.

17 July 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MKMd Alamgir Kabir
Md Alamgir Kabir
RSRuben Soto-Acosta
Ruben Soto-Acosta
SSSandhya Sharma
Sandhya Sharma
SBShelton S. Bradrick
Shelton S. Bradrick
MGMariano A. Garcia-Blanco
Mariano A. Garcia-Blanco
Waseem AsgharWaseem Asghar
Waseem Asghar
Zika virus (ZIKV) is an emerging flavivirus transmitted to humans by Aedes mosquitos. ZIKV can be transmitted from mother to fetus during pregnancy and can cause microcephaly and other birth defects. Effective vaccines for Zika are yet to be approved. Detection of the ZIKV is based on serological testing that often shows cross-reactivity with the Dengue virus (DENV) and other flaviviruses. We aimed to assemble a highly specific anti-Zika antibody panel to be utilized in the development of a highly specific and cost-effective ZIKV rapid quantification assay for viral load monitoring at point-of-care settings. To this end, we tested the affinity and specificity of twenty one commercially available monoclonal and polyclonal antibodies against ZIKV and DENV envelope proteins utilizing nine ZIKV and twelve DENV strains. We finalized and tested a panel of five antibodies for the specific detection and differentiation of ZIKV and DENV infected samples.